Table 4.
Relationship of cancer- and host-related characteristics with overall survival (OS) in 109 patients with ovarian clear cell carcinoma
| Characteristics | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Age (yr) (≥50 vs. <50) | 1.451 (0.730-2.885) | 0.287 | ||
| FIGO stage (III/IV vs. I/II) | 9.330 (3.823-22.766) | < 0.001 | 5.587 (1.951-15.999) | 0.001 |
| LN metastasis (Yes vs. No) | 2.928 (1.416-6.056) | 0.004 | 1.073 (0.439-2.619) | 0.878 |
| Malignant ascites (Yes vs. No) | 4.095 (2.006-8.358) | < 0.001 | 1.223 (0.479-3.126) | 0.674 |
| Endometriosis (No vs. Yes) | 4.827 (1.155-20.178) | 0.039 | 2.115 (0.669-6.935) | 0.263 |
| CA-125 (Unit/mL) (≥88.2 vs. <88.2) | 3.732 (1.674-8.319) | 0.001 | 1.720 (0.587-4.8866) | 0.578 |
| Residual mass (≥1 cm vs. <1 cm) | 4.847 (2.361-9.952) | < 0.001 | 3.408 (1.434-8.099) | 0.011 |
| Platinum response (Resistant vs. Sensitive) | 8.403 (4.044-17.459) | < 0.001 | 3.167 (1.023-7.086) | 0.031 |
| NLR (≥2.3 vs. <2.3) | 5.071 (1.546-16.633) | 0.007 | 2.145 (0.529-8.700) | 0.285 |
| LMR (<4.2 vs. ≥4.2) | 6.603 (2.015-21.646) | 0.001 | 2.655 (0.889-8.926) | 0.038 |
| PLR (≥123.6 vs. <123.6) | 1.393 (0.490-3.962) | 0.535 | ||
HRs was obtained from Cox's proportional hazard model. HR, hazard ratio; CI, confidence interval; NLR, neutrophil-lymphocyte ratio; LMR, lymphocyte-monocyte ratio; PLR, platelet-lymphocyte ratio; FIGO, The International Federation of Gynecology and Obstetrics; LN, lymph node; CA-125, cancer antigen 125